Stay updated on Dose Determination and Efficacy of Vesleteplirsen Clinical Trial

Sign up to get notified when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T20:25:00.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include the EudraCT number for a study on Duchenne Muscular Dystrophy and a revision number change from v2.14.4 to v2.15.0. Significant details regarding the study's design and participant criteria have been removed.
    Difference
    22%
    Check dated 2025-04-16T13:55:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 10, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T08:41:53.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The study for the drug vesleteplirsen has been terminated, and the details regarding its dosing and participant enrollment have been updated, including a new last update date of March 2025.
    Difference
    5%
    Check dated 2025-03-11T04:28:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:47:39.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:51:13.000Z thumbnail image

Stay in the know with updates to Dose Determination and Efficacy of Vesleteplirsen Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.